Position in APGE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$48,231,292
+$14,097,160 QoQ
Shares Held
363,379
-10.4% QoQ
Ownership
0.480%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#41
of 285 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in APGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. APGE ranks #39 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in APGE
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,231,292 | 363,379 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $34,134,132 | 405,538 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $34,041,629 | 451,002 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $29,033,133 | 730,761 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $37,025,420 | 852,531 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $32,730,199 | 876,076 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $39,238,316 | 866,188 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $50,574,493 | 860,989 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $39,565,244 | 1,005,470 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $68,801,001 | 1,035,380 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $30,448,453 | 1,089,780 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $21,243,704 | 997,357 | Shares | Defined | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||